
Rights Issue3 Nov 2026, 05:50 pm
Indrayani Biotech Approves Rights Issue Allotment
AI Summary
Indrayani Biotech Limited's Rights Issue Committee has approved the Basis of Allotment for 83,64,036 Rights Equity Shares. These shares, with a face value of ₹10 each, were issued at ₹15 per share, with an application money of ₹3.75 received per share. The approval, finalized in consultation with BSE Limited, results in an increase in the company's paid-up equity share capital. The total paid-up capital now comprises 5,30,39,589 fully paid-up equity shares and 8,60,703 partly paid-up equity shares.
Key Highlights
- Rights Issue Committee approved Basis of Allotment.
- 83,64,036 Rights Equity Shares allotted.
- Paid-up equity share capital has increased.
- Company now has fully and partly paid-up shares.
Price Impact
More from INDRANIB